ArticleLancet regional health. Americas2023
Post-incarceration outcomes of a comprehensive statewide correctional MOUD program: a retrospective cohort study.
Article in Lancet regional health. Americas, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 30 citations in OpenAlex.
- Assessing the comparative effectiveness of ECHO and coaching implementation strategies in a jail/provider MOUD implementation trial.Implementation science : IS · 2025Trial
- HIV Risk and Interest in Preexposure Prophylaxis in Justice-Involved Persons.Emerging infectious diseases · 2024Trial
- Patient preferences for medications to treat opioid use disorder in carceral settings: Implications for tailored implementation and service delivery.Journal of substance use and addiction treatment · 2026Article
- "Once I started going… I had this central wheel hub": Drivers of overdose prevention center engagement and connections to care in Rhode Island.The International journal on drug policy · 2026Article
- Impact of social determinants on opioid use disorder treatment engagement after release from jail: a case note content analysis.Addiction science & clinical practice · 2026Article
- Retrospective Cohort Study of The Lovelady Center: A large Faith-Based Residential Recovery Program for Women with Substance Use Disorders in the USA.Journal of religion and health · 2026Article
- Responding to the increase in substance use, HIV, HCV, and overdose in New England (RISE-NE): Protocol for a prospective cohort study.PloS one · 2026Article
- Association between vaccine uptake and SARS-CoV-2 infection among staff at a jail and prison in the USA.International journal of prison health · 2025Article
- Multilevel determinants of medication preferences for opioid use disorder among criminal-legal-involved populations: Insights from a scoping review.Drug and alcohol dependence reports · 2025Review
- Allocative efficiency of opioid overdose prevention strategies for people incarcerated in New Jersey.Harm reduction journal · 2025Article
- Implementation of harm reduction strategies in criminal-legal systems: a scoping review of the literature.Health & justice · 2025Review
- Medications for Opioid Use Disorder in County Jails - Outcomes after Release.The New England journal of medicine · 2025Observational
- A mixed-method exploratory assessment of provider-based stigma of opioid use disorder (OUD) and support for medications for opioid use disorder (MOUD) in carceral settings.Harm reduction journal · 2025Article
- Pilot of Methadone for Recently Incarcerated People with Human Immunodeficiency Virus and Opioid Use in South Africa.Journal of correctional health care : the official journal of the National Commission on Correctional Health Care · 2025Article
- Evaluating public health vending machine rollout and utilization in criminal-legal settings.Journal of substance use and addiction treatment · 2025Article
- Racial Differences in Medications for Opioid Use Disorder Initiation in a Carceral Setting.Substance use & addiction journal · 2025Article
- Serving justice-involved persons and the opioid epidemic.Lancet regional health. Americas · 2024Article
- Receipt of medications for opioid use disorder before and after incarceration in Massachusetts State prisons, 2014-2019.Drug and alcohol dependence · 2024Article
- "Expected to happen": perspectives on post-release overdose from recently incarcerated people with opioid use disorder.Harm reduction journal · 2024Article
- Identifying structural risk factors for overdose following incarceration: a concept mapping study.Health & justice · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 6 institutions in 1 country.
Funding
Abstract
Background: As opioid overdoses surge, medications for opioid use disorder (MOUD) remain underutilized. MOUD is rarely offered in correctional facilities although individuals involved in the criminal justice system have higher rates of OUD and mortality relative to the general population. Methods: A retrospective cohort design examined the effect of MOUD while incarcerated on 12 months post-release treatment engagement and retention, overdose mortality, and recidivism. Individuals (N = 1600) who participated in the Rhode Island Department of Corrections (RIDOC) MOUD program (the United States' first statewide program) and were released from incarceration from December 1, 2016, to December 31, 2018, were included. The sample was 72.6% Male (27.4% female) and 80.8% White (5.8% Black, 11.4% Hispanic, 2.0% another race). Findings: 56% were prescribed methadone, 43% buprenorphine, and 1% naltrexone. During incarceration, 61% were continued on MOUD from the community, 30% were inducted onto MOUD upon incarceration, and 9% were inducted pre-release. At 30 days and 12 months post-release, 73% and 86% of participants engaged in MOUD treatment, respectively, and those newly inducted had lower post-release engagement than those who continued from the community. Reincarceration rates (52%) were similar to the general RIDOC population. Twelve overdose deaths occurred during the 12-month follow-up, with only one overdose death during the first two weeks post-release. Interpretations: Implementing MOUD in correctional facilities, with seamless linkage to community care is a needed life-saving strategy. Funding: Rhode Island General Fund, the NIH of Health HEAL Initiative, the NIGMS, and the NIDA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.